The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-((6-methylpyrimidin-4-yl)methyl)-1-(1-methylpyrrolidin-3-yl)-1H-imidazo[4,5-c]quinoline-8-carbonitrile ID: ALA4521173
PubChem CID: 135325140
Max Phase: Preclinical
Molecular Formula: C22H21N7
Molecular Weight: 383.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(Cc2nc3cnc4ccc(C#N)cc4c3n2[C@@H]2CCN(C)C2)ncn1
Standard InChI: InChI=1S/C22H21N7/c1-14-7-16(26-13-25-14)9-21-27-20-11-24-19-4-3-15(10-23)8-18(19)22(20)29(21)17-5-6-28(2)12-17/h3-4,7-8,11,13,17H,5-6,9,12H2,1-2H3/t17-/m1/s1
Standard InChI Key: NZGUBUFNKSWTBS-QGZVFWFLSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
29.2455 -2.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1760 -3.2212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9932 -3.2212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5846 -1.9624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9258 -2.4445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1485 -2.1924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4727 -3.8829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1888 -5.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1876 -5.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8957 -6.3215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8939 -4.6841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6025 -5.0894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6033 -5.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3118 -6.3154 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0201 -5.9046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3062 -4.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0120 -5.0835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6148 -4.5372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2814 -3.7951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6876 -3.0860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5048 -3.0832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4810 -4.6845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7732 -4.2761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9124 -3.7925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7288 -3.7901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1358 -3.0805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7205 -2.3718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9054 -2.3777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1395 -4.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 1 1 0
1 4 1 0
4 5 1 0
5 2 1 0
5 6 1 0
8 9 2 0
9 10 1 0
10 13 2 0
12 11 2 0
11 8 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 17 1 0
16 12 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 7 1 0
7 16 1 0
19 20 1 0
20 21 1 0
8 22 1 0
22 23 3 0
3 7 1 1
21 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 21 1 0
25 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.46Molecular Weight (Monoisotopic): 383.1858AlogP: 3.02#Rotatable Bonds: 3Polar Surface Area: 83.52Molecular Species: BASEHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.00CX LogP: 2.01CX LogD: 0.40Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.54Np Likeness Score: -1.30